Hologic to Showcase Products Across Breast Cancer Screening, Biopsy, Surgery and Treatment at Virtual RSNA 2020
Leader in women’s health, first in prestigious
IMV rankings, to host innovative digital product experiences and
medical education sessions
Hologic, Inc. (Nasdaq: HOLX) will virtually showcase its
extensive portfolio of breast and skeletal health products,
including screening, surgical, interventional, ultrasound and
skeletal solutions, at the 106th Scientific Assembly and Annual
Meeting of the Radiological Society of North America (RSNA) from
Nov. 29 to Dec. 5.
As a world leader in women’s healthcare, Hologic provides
insight-driven solutions that encompass the full clinical continuum
of breast health. By addressing the entire patient pathway, these
innovations improve workflow efficiency, reduce facility costs and
improve patient outcomes, all of which are crucial now amid the
Hologic most recently ranked first in customer satisfaction,
mammography service and system performance on the 2020 IMV
ServiceTrack™ Diagnostic Imaging report, a yearly customer
satisfaction survey of the medical imaging field. The honor
underscores the Company’s long-standing commitment to innovation,
excellence and unmatched service.
Although this year’s RSNA conference will be virtual due to
COVID-19 safety precautions and travel restrictions, the Company
remains committed to offering innovation and education to attendees
through an interactive and engaging virtual experience. Visitors to
HologicRSNA.com can tour 3D screening, diagnostic, breast biopsy
and breast surgery product suites virtually; request personalized
product demonstrations with a women’s health expert aboard the
Company’s mobile coach bus via video conferencing; and register for
world-class medical education sessions with leading experts in the
“Throughout the ongoing pandemic, our Hologic team and the
industry as a whole have been incredibly resilient and inventive,
providing remarkable solutions and service amid increasingly
challenging circumstances,” said Jennifer Meade, Hologic’s Division
President, Breast and Skeletal Health Solutions. “This year’s
virtual conference reflects a collective commitment to moving the
industry forward in a changed world. We’re excited to showcase the
proven benefits our ecosystem of superior solutions can have for
both providers and patients.”
According to a 2020 MedPanel™ survey commissioned by the
Company, the majority of breast radiologists who plan on attending
the virtual conference intend to spend between three to six hours
at product demonstrations and seven hours or more participating in
medical education sessions. To meet the needs of this year’s
attendees, Hologic will host a number of medical education sessions
with leading experts throughout the event:
- Managing Patients on the Continuum from Breast Screening to
Diagnosis into Survivorship; An Interdisciplinary Power Hour
Nila H. Alsheik, M.D., Andrew Lee, M.D., and Anna Beth Katz, M.D.
Monday, Nov. 30: 7:00am – 8:00am CST
- Clinical Benefits of Ultrasound and Shear Wave Elastography
in Evaluating Breast Lesion (CME accredited by WCCME*) Stacy
Smith-Foley, M.D. Tuesday, Dec. 1: 7:00am – 8:00am CST
- New Era of Breast Tomosynthesis: High Resolution Imaging
with 3DQuorum™ Technology Terri, Gizienski, M.D., MPH Tuesday,
Dec. 1: 12:30pm – 1:30pm CST
- Implementing Contrast Enhanced Digital Mammography into your
Practice (CME accredited by WCCME*) Stephen L. Rose, M.D.
Wednesday, Dec. 2: 7:00am – 8:00am CST
- Clinical Perspective on 3D™ Guided Breast Biopsy and
Real-Time Specimen Imaging Harriet Borofsky, M.D. Wednesday,
Dec. 2: 12:30pm – 1:30pm CST
For more information on Hologic’s RSNA 2020 offerings or to RSVP
for a medical education session, please visit HologicRSNA.com.
Hologic, Inc. is an innovative medical technology company
primarily focused on improving women's health and well-being
through early detection and treatment. For more information on
Hologic, visit www.hologic.com.
3D, 3DQuorum, Hologic and The Science of Sure are trademarks
and/or registered trademarks of Hologic, Inc., and/or its
subsidiaries in the United States and/or other countries.
This news release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic’s Breast Health products. There can be no assurance
these products will achieve the benefits described herein or that
such benefits will be replicated in any particular manner with
respect to an individual patient, as the actual effect of the use
of the products can only be determined on a case-by-case basis. In
addition, there can be no assurance that these products will be
commercially successful or achieve any expected level of sales.
Hologic expressly disclaims any obligation or undertaking to
release publicly any updates or revisions to any such statements
presented herein to reflect any change in expectations or any
change in events, conditions or circumstances on which any such
data or statements are based.
This information is not intended as a product solicitation or
promotion where such activities are prohibited. For specific
information on what products are available for sale in a particular
country, please contact a local Hologic sales representative or
write to email@example.com.
SOURCE: Hologic, Inc.
*World Class CME is accredited by the Accreditation Council for
Continuing Medical Education for Physicians and designates this
activity for a maximum of 1 AMA PRA Category 1 Credit™. Attendees
should claim only the credit commensurate with the extent of their
participation in the activity. This activity is supported by an
educational grant from Hologic.
version on businesswire.com: https://www.businesswire.com/news/home/20201127005067/en/
Jane Mazur 508.263.8764 (direct) 585.355.5978 (mobile)